There are 1105 resources available
288P - The role of organ-specific response to enfortumab vedotin on survival in advanced urothelial carcinoma patients: A Japanese multicenter retrospective study
Presenter: Nozomi Hayakawa
Session: Poster Display session
Resources:
Abstract
289P - Difference in oncological efficacy between subsequent anti-PD-L1 and anti-PD-1 inhibitors following first-line platinum-based chemotherapy for patients with advanced urothelial carcinoma
Presenter: Ryotaro Kawashima
Session: Poster Display session
Resources:
Abstract
290P - Impact of SBRT in oligometastatic renal cell carcinoma: A spotlight on the unexplored
Presenter: Anu Radha P
Session: Poster Display session
Resources:
Abstract
291P - Cardiotoxicity profile of renal carcinoma treated with immune checkpoint inhibitors: A meta-analysis of phase II/III randomized clinical trials
Presenter: Annisa Nugrahani
Session: Poster Display session
Resources:
Abstract
292P - Avelumab + axitinib (A + Ax) vs sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC): Subgroup analyses by age from the final analysis of the phase III JAVELIN Renal 101 trial
Presenter: John Haanen
Session: Poster Display session
Resources:
Abstract
293P - Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of renal cell carcinoma
Presenter: Dingwei Ye
Session: Poster Display session
Resources:
Abstract
294P - Tolerability and outcomes of definitive chemoradiotherapy for elderly patients with muscle invasive bladder cancer
Presenter: Wonguen Jung
Session: Poster Display session
Resources:
Abstract
295P - Real-world efficacy and safety of lenvatinib plus pembrolizumab in metastatic renal cell carcinoma patients with intermediate and poor risk
Presenter: Ilya Tsimafeyeu
Session: Poster Display session
Resources:
Abstract
297P - Comparative genomic and clinical features between malignant renal epithelioid angiomyolipoma and benign angiomyolipoma
Presenter: Anwaier Aihetaimujiang
Session: Poster Display session
Resources:
Abstract
298P - Radiotherapy combined with low-dose paclitaxel plus cisplatin for very high risk non-muscular invasive bladder cancer: A single-arm, single-center, prospective trial
Presenter: Fang Yuan
Session: Poster Display session
Resources:
Abstract